EI
AZN icon

Ethic Inc’s AstraZeneca AZN Stock Holding History

Ethic Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75M Buy
51,420
+15,814
+44% +$2.97M 0.12% 163
2026
Q1 		$7.02M Sell
35,606
-12,745
-26% -$2.46M 0.11% 198
2025
Q4 		$8.89M Buy
48,351
+6,160
+15% +$1.08M 0.14% 145
2025
Q3 		$6.47M Buy
42,191
+5,819
+16% +$881K 0.11% 188
2025
Q2 		$5.08M Sell
36,372
-2,638
-7% -$370K 0.09% 231
2025
Q1 		$5.66M Sell
39,010
-9,794
-20% -$1.42M 0.11% 198
2024
Q4 		$6.4M Buy
48,804
+3,237
+7% +$453K 0.13% 168
2024
Q3 		$6.17M Sell
45,567
-8,303
-15% -$1.34M 0.16% 153
2024
Q2 		$8.4M Buy
53,870
+8,303
+18% +$1.25M 0.2% 104
2024
Q1 		$6.17M Buy
45,567
+2,079
+5% +$275K 0.16% 153
2023
Q4 		$5.86M Buy
43,488
+4,197
+11% +$546K 0.17% 135
2023
Q3 		$5.32M Buy
39,291
+1,714
+5% +$234K 0.19% 122
2023
Q2 		$5.38M Buy
37,577
+396
+1% +$58.3K 0.2% 113
2023
Q1 		$5.16M Sell
37,181
-2,417
-6% -$325K 0.21% 121
2022
Q4 		$5.37M Buy
39,598
+5,679
+17% +$712K 0.29% 79
2022
Q3 		$3.72M Sell
33,919
-1,922
-5% -$244K 0.25% 101
2022
Q2 		$4.74M Buy
35,841
+4,131
+13% +$542K 0.33% 68
2022
Q1 		$4.21M Buy
31,710
+12,535
+65% +$1.5M 0.29% 83
2021
Q4 		$2.23M Sell
19,175
-289
-1% -$34K 0.17% 144
2021
Q3 		$2.34M Buy
19,464
+6,185
+47% +$720K 0.24% 106
2021
Q2 		$1.59M Buy
13,279
+3,056
+30% +$335K 0.19% 130
2021
Q1 		$1.02M Buy
10,223
+1,166
+13% +$117K 0.18% 150
2020
Q4 		$905K Buy
9,057
+1,778
+24% +$188K 0.24% 103
2020
Q3 		$798K Buy
7,279
+1,013
+16% +$113K 0.31% 86
2020
Q2 		$663K Buy
6,266
+1,221
+24% +$126K 0.38% 64
2020
Q1 		$451K Buy
5,045
+1,056
+26% +$99.4K 0.38% 83
2019
Q4 		$398K Buy
+3,989
New +$376K 0.29% 113

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Ethic Inc's AZN Position: Q2 2026 in Review

Ethic Inc increased its AstraZeneca (AZN) stake by 44% in Q2 2026, buying an estimated $2.97M and bringing the position to 51,420 shares worth $9.75M. The position accounts for 0.12% of the portfolio, ranked #163.

Ethic Inc first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. 578 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Ethic Inc held 51,420 shares of AstraZeneca worth $9.75M as of Q2 2026.
  • Ethic Inc bought 15,814 AstraZeneca shares in Q2 2026, an estimated $2.97M.
  • AstraZeneca made up 0.12% of Ethic Inc's portfolio in Q2 2026, its #163 holding.
  • Ethic Inc first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
  • 578 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.